10:02 AM EST - Valeant Pharmaceuticals International, Inc. : reports the closing of its recently priced public offering of common shares and the exercise in full by the underwriters of their option to purchase additional common shares. The Company today issued 23,529,412 common shares at a price of $85.00 per share and, pursuant to the underwriters' exercise of their option to purchase additional common shares, an additional 3,529,412 common shares at a price of $85.00 per share, for aggregate gross proceeds of approximately $2.3 billion. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $0.05 at $88.71.
